Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.

Objective: To assess central venous catheter (CVC) harm in pediatric oncology patients, we explored risks for central-line-associated bloodstream infections (CLABSIs) and central-line-associated non-CLABSI complications (CLANCs).

Design: Retrospective cohort study.

Setting: Midwestern US pediatric oncology program.